These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 30426328

  • 1. Comparison of Three Real-Time PCR Assays for the Detection of PIK3CA Somatic Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Breast Carcinomas.
    Lambert A, Salleron J, Lion M, Rouyer M, Lozano N, Leroux A, Merlin JL, Harlé A.
    Pathol Oncol Res; 2019 Jul; 25(3):1117-1123. PubMed ID: 30426328
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
    Sie D, Snijders PJ, Meijer GA, Doeleman MW, van Moorsel MI, van Essen HF, Eijk PP, Grünberg K, van Grieken NC, Thunnissen E, Verheul HM, Smit EF, Ylstra B, Heideman DA.
    Cell Oncol (Dordr); 2014 Oct; 37(5):353-61. PubMed ID: 25209392
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A Comparison Between Full-COLD PCR/HRM and PCR Sequencing for Detection of Mutations in Exon 9 of PIK3CA in Breast Cancer Patients.
    Ghalamkari S, Khosravian F, Mianesaz H, Kazemi M, Behjati M, Hakimian SM, Salehi M.
    Appl Biochem Biotechnol; 2019 Mar; 187(3):975-983. PubMed ID: 30109561
    [Abstract] [Full Text] [Related]

  • 10. PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system.
    Shimoi T, Hamada A, Yamagishi M, Hirai M, Yoshida M, Nishikawa T, Sudo K, Shimomura A, Noguchi E, Yunokawa M, Yonemori K, Shimizu C, Kinoshita T, Fukuda T, Fujiwara Y, Tamura K.
    Cancer Sci; 2018 Aug; 109(8):2558-2566. PubMed ID: 29906308
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic Melanoma.
    Franczak C, Salleron J, Dubois C, Filhine-Trésarrieu P, Leroux A, Merlin JL, Harlé A.
    Mol Diagn Ther; 2017 Apr; 21(2):209-216. PubMed ID: 28130756
    [Abstract] [Full Text] [Related]

  • 12. Multiplexed assays for detection of mutations in PIK3CA.
    Board RE, Thelwell NJ, Ravetto PF, Little S, Ranson M, Dive C, Hughes A, Whitcombe D.
    Clin Chem; 2008 Apr; 54(4):757-60. PubMed ID: 18375489
    [Abstract] [Full Text] [Related]

  • 13. A novel PIK3CA hot-spot mutation in breast cancer patients detected by HRM-COLD-PCR analysis.
    Debouki-Joudi S, Ben Kridis W, Trifa F, Ayadi W, Khabir A, Sellami-Boudawara T, Daoud J, Khanfir A, Mokdad-Gargouri R.
    Breast Dis; 2024 Apr; 43(1):213-221. PubMed ID: 38943378
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC.
    J Mol Diagn; 2012 Apr; 14(3):247-55. PubMed ID: 22425762
    [Abstract] [Full Text] [Related]

  • 17. Development and Validation of a Novel Dual-Drop-off ddPCR Assay for the Simultaneous Detection of Ten Hotspots PIK3CA Mutations.
    Stergiopoulou D, Smilkou S, Georgoulias V, Kaklamanis L, Lianidou E, Markou A.
    Anal Chem; 2023 Sep 19; 95(37):14068-14076. PubMed ID: 37681347
    [Abstract] [Full Text] [Related]

  • 18. PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
    Chia SKL, Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Kim SB, Jakobsen EH, Harvey V, Robert N, Smith J, Harker G, Zhang B, Eli LD, Ye Y, Lalani AS, Buyse M, Chan A.
    Breast Cancer Res; 2019 Mar 11; 21(1):39. PubMed ID: 30867034
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A simple and robust real-time qPCR method for the detection of PIK3CA mutations.
    Alvarez-Garcia V, Bartos C, Keraite I, Trivedi U, Brennan PM, Kersaudy-Kerhoas M, Gharbi K, Oikonomidou O, Leslie NR.
    Sci Rep; 2018 Mar 09; 8(1):4290. PubMed ID: 29523855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.